Medicure Inc.
MCUJF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.84 | 0.07 | -0.03 | 0.15 |
| FCF Yield | 6.86% | 17.10% | 13.58% | 33.52% |
| EV / EBITDA | 1.94 | 3.68 | 2.49 | 2.86 |
| Quality | ||||
| ROIC | -16.77% | -4.29% | 5.91% | -2.71% |
| Gross Margin | 59.75% | 64.48% | 69.69% | 58.46% |
| Cash Conversion Ratio | -1.33 | -2.25 | 1.34 | -5.49 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.70% | -0.08% | 25.71% | 2.53% |
| Free Cash Flow Growth | -64.73% | 19.17% | -52.13% | 241.44% |
| Safety | ||||
| Net Debt / EBITDA | -4.10 | -4.51 | -1.40 | -1.04 |
| Interest Coverage | -273.70 | -85.40 | 0.00 | -15.11 |
| Efficiency | ||||
| Inventory Turnover | 2.69 | 2.66 | 2.17 | 2.71 |
| Cash Conversion Cycle | -104.20 | -120.86 | -82.41 | -50.52 |